124 related articles for article (PubMed ID: 2415587)
1. The CD20 (Bp35) antigen is involved in activation of B cells from the G0 to the G1 phase of the cell cycle.
Golay JT; Clark EA; Beverley PC
J Immunol; 1985 Dec; 135(6):3795-801. PubMed ID: 2415587
[TBL] [Abstract][Full Text] [Related]
2. Activation of human B cells: alternate options for initial triggering and effects of nonmitogenic concentrations of anti-IgM antibodies on resting and activated cells.
Smeland EB; Beiske K; Ohlsson R; Holte H; Ruud E; Blomhoff HK; Jefferis R; Godal T
J Immunol; 1987 May; 138(10):3179-84. PubMed ID: 3553323
[TBL] [Abstract][Full Text] [Related]
3. The B cell surface molecule B1 is functionally linked with B cell activation and differentiation.
Tedder TF; Boyd AW; Freedman AS; Nadler LM; Schlossman SF
J Immunol; 1985 Aug; 135(2):973-9. PubMed ID: 3925015
[TBL] [Abstract][Full Text] [Related]
4. B cell activation. V. Differentiation signaling of B cell membrane depolarization, increased I-A expression, G0 to G1 transition, and thymidine uptake by anti-IgM and anti-IgD antibodies.
Cambier JC; Monroe JG
J Immunol; 1984 Aug; 133(2):576-81. PubMed ID: 6610706
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of cell activation markers after stimulation of resting human B lymphocytes.
Kehrl JH; Muraguchi A; Fauci AS
J Immunol; 1984 Jun; 132(6):2857-61. PubMed ID: 6427329
[TBL] [Abstract][Full Text] [Related]
6. Cognate interactions between helper T cells and B cells. III. Contact-dependent, lymphokine-independent induction of B cell cycle entry by activated helper T cells.
Noelle RJ; McCann J; Marshall L; Bartlett WC
J Immunol; 1989 Sep; 143(6):1807-14. PubMed ID: 2476483
[TBL] [Abstract][Full Text] [Related]
7. Ligation of the CD23,p45 (BLAST-2,EBVCS) antigen triggers the cell-cycle progression of activated B lymphocytes.
Gordon J; Rowe M; Walker L; Guy G
Eur J Immunol; 1986 Sep; 16(9):1075-80. PubMed ID: 2428624
[TBL] [Abstract][Full Text] [Related]
8. Activation of human B cell proliferation through surface Bp35 (CD20) polypeptides or immunoglobulin receptors.
Clark EA; Shu G
J Immunol; 1987 Feb; 138(3):720-5. PubMed ID: 3492530
[TBL] [Abstract][Full Text] [Related]
9. Separate control of B lymphocyte early activation and proliferation in response to anti-IgM antibodies.
DeFranco AL; Raveche ES; Paul WE
J Immunol; 1985 Jul; 135(1):87-94. PubMed ID: 3873499
[TBL] [Abstract][Full Text] [Related]
10. Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp 130/140.
Pezzutto A; Dörken B; Moldenhauer G; Clark EA
J Immunol; 1987 Jan; 138(1):98-103. PubMed ID: 3097151
[TBL] [Abstract][Full Text] [Related]
11. Cyclic AMP has the ability to influence multiple events during B cell stimulation.
Holte H; Torjesen P; Blomhoff HK; Ruud E; Funderud S; Smeland EB
Eur J Immunol; 1988 Sep; 18(9):1359-66. PubMed ID: 2458941
[TBL] [Abstract][Full Text] [Related]
12. Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytes.
Tedder TF; Forsgren A; Boyd AW; Nadler LM; Schlossman SF
Eur J Immunol; 1986 Aug; 16(8):881-7. PubMed ID: 3091375
[TBL] [Abstract][Full Text] [Related]
13. The roles of T cell factors in activation, cell cycle progression, and differentiation of human B cells.
Jelinek DF; Lipsky PE
J Immunol; 1985 Mar; 134(3):1690-701. PubMed ID: 3871457
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies that inhibit activation and proliferation of lymphocytes. II. Requisite role of the monoclonal antibody-defined antigen systems in activation and proliferation of human and rat lymphocytes.
Yagita H; Hashimoto Y
J Immunol; 1986 Mar; 136(6):2062-8. PubMed ID: 2419421
[TBL] [Abstract][Full Text] [Related]
15. Supernatant from a cloned helper T cell stimulates most small resting B cells to undergo increased I-A expression, blastogenesis, and progression through cell cycle.
Leclercq L; Cambier JC; Mishal Z; Julius MH; Theze J
J Immunol; 1986 Jan; 136(2):539-45. PubMed ID: 2416811
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle.
Muraguchi A; Miyazaki K; Kehrl JH; Fauci AS
J Immunol; 1984 Sep; 133(3):1283-7. PubMed ID: 6086754
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD45 inhibition of human B cell proliferation depends on the nature of activation signals and the state of B cell activation. A study with anti-IgM and anti-CDw40 antibodies.
Gruber MF; Bjorndahl JM; Nakamura S; Fu SM
J Immunol; 1989 Jun; 142(12):4144-52. PubMed ID: 2470814
[TBL] [Abstract][Full Text] [Related]
18. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
19. Functional studies on B cell hybridomas with B cell surface antigens. I. Effects of anti-immunoglobulin antibodies on proliferation and differentiation.
Hamano T; Asofsky R
J Immunol; 1983 May; 130(5):2027-32. PubMed ID: 6403617
[TBL] [Abstract][Full Text] [Related]
20. CR2 ligands modulate human B cell activation.
Bohnsack JF; Cooper NR
J Immunol; 1988 Oct; 141(8):2569-76. PubMed ID: 2459218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
